Showing results (361-370 of 474) with videos related to
Sort By:
Pageof 48
Cancer Medicine|September 16, 2025
"Quite Devastating, Traumatic, and Lonely": Understanding the Mental Health Experiences of Hispanic/Latino Rectal Cancer Patients and Their CaregiversZaria N Cosby, Julian P Howland, Eleanor Brown, et al.Journal of Genetic Counseling|September 25, 2023
Promotores' perspectives on the virtual adaptation of a hereditary breast cancer education programFabian Perez, Miriam Hernandez, Alejandra Martinez, et al.Nature Communications|December 3, 2025
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trialPanagiotis A Konstantinopoulos, Ningxuan Zhou, Richard T Penson, et al.Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.Frontiers in Medicine|July 5, 2022
Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative ColitisMaria Gonzalez-Vivo, Minna K Lund Tiirikainen, Montserrat Andreu, et al.American Journal of Industrial Medicine|November 19, 2009
Occupational health crossing borders part 2: Comparison of 18 occupational health systems across the globeKatja Radon, Vera Ehrenstein, Dennis Nowak, et al.Cancers|February 25, 2022
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell LymphomaGrégoire Quinet, Wendy Xolalpa, Diana Reyes-Garau, et al.Proceedings of the National Academy of Sciences of the United States of America|November 10, 2010
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cellsSven Jähnichen, Christophe Blanchetot, David Maussang, et al.Archives of General Psychiatry|December 10, 2003
A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute maniaMauricio Tohen, Joseph F Goldberg, Ana Maria Gonzalez-Pinto Arrillaga, et al.The Journal of Biological Chemistry|August 28, 2013
Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivoDavid Maussang, Azra Mujić-Delić, Francis J Descamps, et al.Pageof 48